A prominent U.S. lawmaker may be upset that AbbVie ties the bonus given chief executive Richard Gonzalez to sales of the Humira rheumatoid arthritis treatment but most shareholders seem unconcerned. httpsbuff.ly2vET6GNÂ

A prominent U.S. lawmaker may be upset that AbbVie ties the bonus given chief executive Richard Gonzalez to sales of the Humira rheumatoid arthritis treatment, but most shareholders seem unconcerned. https://buff.ly/2vET6GN 

22:00 EDT 4 May 2019 | STAT

A prominent U.S. lawmaker may be upset that AbbVie ties the bonus given chief executive Richard Gonzalez to sales of the Humira rheumatoid arthritis treatment, but most shareholders seem unconcerned. https://buff.ly/2vET6GN 

More From BioPortfolio on "A prominent U.S. lawmaker may be upset that AbbVie ties the bonus given chief executive Richard Gonzalez to sales of the Humira rheumatoid arthritis treatment, but most shareholders seem unconcerned. https://buff.ly/2vET6GN "